The ongoing conflict in Iran is causing significant disruption to global supply chains, raising fears of shortages of essential medicines in the UK. The National Health Service (NHS) relies heavily on imports of pharmaceutical ingredients and finished drugs, many of which are sourced from the Middle East and Asia. With shipping routes affected and production facilities under threat, there are growing concerns that patients may face delays in accessing critical treatments.
The conflict has already led to soaring energy costs, which are impacting the production and transportation of medicines. The price of oil and gas has risen dramatically, increasing the cost of manufacturing drugs and running cold storage facilities. This could lead to higher prices for medicines and potential shortages if production is scaled back.
Experts warn that the situation could worsen if the conflict continues. The NHS has contingency plans in place, but these may not be sufficient to cope with prolonged disruption. The government is being urged to take action to secure supply chains and ensure that patients continue to receive the medicines they need.
